PMID: 25274209

Hayashi H
[Development of new therapeutic strategy for transporter-related diseases].
Yakugaku Zasshi. 2014;134(10):1007-11., [PubMed]
Sentences
No. Mutations Sentence Comment
12 ABCB11 p.Asp482Gly
X
ABCB11 p.Asp482Gly 25274209:12:2479
status: NEW
view ABCB11 p.Asp482Gly details
ABCB11 p.Asp482Gly
X
ABCB11 p.Asp482Gly 25274209:12:3334
status: NEW
view ABCB11 p.Asp482Gly details
ABCB11 p.Asp482Gly
X
ABCB11 p.Asp482Gly 25274209:12:3600
status: NEW
view ABCB11 p.Asp482Gly details
ABCB11 p.Glu297Gly
X
ABCB11 p.Glu297Gly 25274209:12:2311
status: NEW
view ABCB11 p.Glu297Gly details
ABCB11 p.Glu297Gly
X
ABCB11 p.Glu297Gly 25274209:12:3327
status: NEW
view ABCB11 p.Glu297Gly details
ABCB11 p.Glu297Gly
X
ABCB11 p.Glu297Gly 25274209:12:3593
status: NEW
view ABCB11 p.Glu297Gly details
BSEP Expression on the Canalicular Membrane Is Decreased in Patients with PFIC25) 1008 Vol. 134 (2014) d3b;ឋf5c;ᵨఌa2;dd;c8;fc;b7;b9;fc3;⍈f5c;ᵨఔecb;௱ıf;d30;Pde;bd2;ឋ IJb;ఐĴa;,[cd;be4;IJa;̩d;a5f;Pfd;ωc;bb3;İc;f15;İd;d77;௭௯Ĵc;Ĵb;&#ff0e;ᱯIJb; [cd;be4;IJa;̩d;ᑁPc6;c41;௦௷ede;ఔᕈ௳Ĵb;Kbe;<a3;IJe;e00;f8b;௼௱௺, BSEP IJe;΋a;f1d;b50;᜕ᶒIJb;d77;8e0;௱௺˿a;Kc7;௳Ĵb;e0c;c11;`e3;cbb;ឋ Kbe;<a3;IJe; PFIC2 İc;Me5;఑Ĵc;௺௤Ĵb;&#ff0e; 3,4) PFIC2 IJb;bfe;௱௺ IJf;,Ife;Hb6;௻IJf;ᑁOd1;Ḅᷚcd5;İc;Nba;acb;௱௺İa;఑ıa;,̩d;Ofb;ʲd; ఔ5d7;௫IJa;௫Ĵc;௾,əd;᧡ʟf;Ȍd;IJb;Qf4;b7b;ឋIJe;d4c;Έe;ఔfbf;Ĵb;&#ff0e; ̩d;Ofb;ʲd;IJf;˯f;Ḽ௳Ĵb;İb;௽௦İb;İc;Nba;b9f;௻IJf;IJa;İf;ea;b9;af;İc; ad8;௤௭௼, ad8;Ϙd;IJa;ɰb;⊕cbb;İc;İb;İb;Ĵb;௭௼,௯఑IJb;Ȃd;Kab; ᢓᑴᒐఔe00;˯f;ʞd;ᵨ௱d9a;௫IJa;İf;௺IJf;IJa;఑IJa;௤௭௼IJa;௽ İb;఑,<a3;ὅIJb;ᾙf53;Ḅ,[d1;\ad;ḄIJb;ɏa;ᜧIJa;ca0;>c5;ఔf37;௤Ĵb; cbb;ᷚcd5;௻௢Ĵb;&#ff0e;௱ıf;İc;௷௺,PFIC2 IJb;bfe;௳Ĵb;ȕb;Uac; 6c1;IJe;ξb;˿a;İc;ᑗʟb;௯Ĵc;௺௤Ĵb;&#ff0e; ee5;e0a;IJe;Pcc;ʚf;İb;఑,b46;ὅIJf;,PFIC2 <a3;ὅIJe; 60%ee5; e0a;İc;fdd;8e0;௳Ĵb; 297 ˴a;Lee;IJe;b0;eb;bf;df;f3;⏚İc;b0;ea;b7;f3;IJb; ee3;Ĵf;Ĵb;᜕ᶒf53;(E297G) ,482 ˴a;Lee;IJe;a2;b9;d1;e9;ae;f3; ⏚İc;b0;ea;b7;f3;IJb;ee3;Ĵf;Ĵb;᜕ᶒf53;(D482G)IJe; 2 ௸IJe; d2;c8; BSEP ᜕ᶒf53;˿a;Ife;d30;Pde;ఔEcb;bc9;௱,a2e;஽IJe; in vitro b9f; a13;ఔb9f;Abd;௱ıf;&#ff0e; 5) ıd;IJe;d50;ʧc;,e21;᜕ᶒİc; BSEP IJe;e0d;b89;b9a;ᓄIJb;2cd;İd;,BSEP IJe;d30;Pde;̳c;˿a;Ife;[cf;ఔf4e;e0b;௯ ıb;௺௤Ĵb;௭௼ఔ΂b;௤3fa;௱ıf;(Fig. 1) &#ff0e;ıd;IJe;e00;Ab9;௻, e21; BSEP ᜕ᶒf53;ఔ˿a;Ife;௯ıb;ıf;d30;Pde;İb;఑d30;Pde;̳c;d9;b7; af; eb; ఔ abf; Xfd; ௱ , f38; 〈 b9f; a13; ఔ b9f; Abd; ௱ ıf; ௼ ௭ Ĵd; , E297G, D482G İc;ᓮf4d; BSEP [cf;f53;ıf;Ĵa;IJe;Pc6;c41;⏚f38;〈 d3b;ឋIJb;IJf;f71;aff;ఔe0e;௨IJa;௤௭௼İc;ʔe;఑İb;௼IJa;௷ıf;&#ff0e; E297G, D482G ᜕ᶒఔᢝ௸ PFIC2 <a3;ὅIJe;̩d;d44;e54; ఔᵨ௤ıf;Ȃd;Kab;d44;e54;Cd3;⁐cd5;௻IJf;,bdb;d30;Pc6;ba1;Ꮢ̳c;e0a;IJb;İa; ௫Ĵb; BSEP ˿a;Ife;[cf;İc;♿℉IJb;f4e;e0b;௱௺İa;Ĵa;, 4) Ĵf;Ĵc;Ĵf; Ĵc;IJe; in vitro Ye3;᪆d50;ʧc;௼̺f;ɕd;IJa;Lf8;_a2;İc;a8d;ఉ఑Ĵc;௺௤ Ĵb;&#ff0e;௱ıf;İc;௷௺,eca;f8c;Ǵb;஽IJe; PFIC2 <a3;ὅIJe;Kc5;ɦb;˿a; Kc7;a5f;Ecb;ఔe88;e2c;௳Ĵb;e0a;௻,b46;ὅIJe;b9f; a13;cfb;IJf;Ϗe;e38;IJb;ᨵᵨ IJa;c4;fc;eb;௼IJa;Ĵb;௭௼İc;ʟf;f85;௯Ĵc;Ĵb;&#ff0e; PFIC2 cbb;ᷚUac;IJe;?a2;d22; b46;ὅ఑IJf;,in vitro b9f; a13;İb;఑,PFIC2 <a3;ὅ௻IJf;ɏa; İf;IJe;ᛊᔠ,BSEP IJe;d30;Pde;̳c;˿a;Ife;[cf;İc;f4e;e0b;௳Ĵb;e00;Ab9; ௻,˿a;Ife;௱௺௤Ĵb; BSEP IJe;Pc6;c41;⏚f38;〈d3b;ឋIJf;fdd;ᢝ ௯Ĵc;௺௤Ĵb;௭௼İb;఑,BSEP IJe;d30;Pde;̳c;˿a;Ife;[cf;ఔᜉ4a0; ௯ıb;Ĵb;Ab9;cd5;ad6;IJe;ξb;˿a;İc;,PFIC2 IJe;ᑁOd1;Ḅᷚcd5;IJe;Nba; acb;IJb;௸IJa;İc;Ĵb;௼ὃ௨ıf;&#ff0e;ᱯIJb;,Qe8;e8a;fc3;ea6;௻ BSEP IJe;d30;Pde;̳c;˿a;Ife;[cf;ఔ ad8;ఉĴb;Uac;4b9;ఔᨵ௳Ĵb;Ae2;b58;ȕb;Uac;6c1;ఔ Ȝc;b9a;௳Ĵb;௭௼İc;௻İd;Ĵc;௾,d4c;e08;Ḅca0;>c5;,5ca;ఁξb;˿a;ea; b9;af;ఔefd;e1b;௱ıf; PFIC2 IJb;bfe;௳Ĵb;Ab0;Uac;ᒛXfd;İc;b9f;Ife;5ef; Pfd;௻௢Ĵb;௼ὃ௨,BSEP IJe;d30;Pde;̳c;˿a;Ife;[cf;IJe;᜕4d5;ఔc21; fbf;İb;௸Med;᧲╹௻a55;fa1;5ef;Pfd;IJa;Hec;Qea;IJe; in vitro b9f; a13;cfb;ఔ Ecb;bc9;௱,a2e;஽IJe;Ae2;b58;ȕb;Uac;6c1;ఔb9;af;ea;fc;cb;f3;b0;௱ıf;&#ff0e; ıd;IJe;d50;ʧc;,⋋ᦪIJe;χd;ឋᓄᔠᱥIJe;Ȝc;b9a;IJb;ᡂȑf;௱ıf; (Fig. 2) &#ff0e;௭Ĵc;఑IJe;χd;ឋᓄᔠᱥIJe;௦௵,d2;c8;IJb;d4c;5e3; ᢗe0e;௱ıf;f8c;,BSEP İc;˿a;Ife;௳Ĵb;̩d;Qd3;IJb;ᑖe03;௳Ĵb;௭௼ İc;ʔe;఑İb;௼IJa;௷௺௤ıf;c3f;d20;b5;a4;af;eb;ᶒe38;Kc7;(urea cycle disorder; UCD ) IJe; cbb; ᷚ Uac; ௻ ௢ Ĵb; 4-phenylbutyrate (4PB)IJb;ḼLee;௱,௯఑IJb;Ẇa76;ఔ⍈ఉĴb;௭ ௼௼௱ıf;&#ff0e; 6) UCD <a3;ὅIJb;bfe;௳Ĵb;Qe8;e8a;ᵨ[cf;IJe; 4PB ఔe9;c3;c8;IJb;d4c; 5e3;ᢗe0e;௱ıf;௼௭Ĵd;,̩d;bdb;d30;Pc6;ba1;Ꮢ̳c;IJb;İa;௫Ĵb; Bsep IJe;˿a;Ife;[cf;ᜉ4a0;,̩d;bdb;d30;Pc6;ba1;Ꮢ̳c;ఔecb;௱ıf;Pc6;c41;⏚f38;〈 IJe;ea2;⍈İc;Yb3;bdf;௯Ĵc;,4PB İc; in vivo ௻ఊȜc;Ed8;IJe;Uac;4b9; ఔ˿a;Ife;௳Ĵb;௭௼İc;Nba;a8d;௯Ĵc;ıf;&#ff0e; 6) ıd;௭௻,b21;IJb;d2;c8; ௻IJe;Uac;4b9;ఔNba;a8d;௳Ĵb;ıf;ఉ,Ƕb;ᳮ;d4;6e1;f1a;IJe;ɳf;a8d;IJe;e0b;, UCD <a3;ὅఔbfe;c61;௼௱ıf;ec;c8;ed;b9;da;af;c6;a3;d6;Ẇa76;ఔ b9f;Abd;௱ıf;&#ff0e;UCD <a3;ὅIJf;,Nba;b9a;a3a;Aad;f8c;,4PB IJe;ʞd;ᵨ ఔξb;;cb;௱,ᨬd42;ḄIJb;IJf;̩d;Ofb;ʲd;ఔ5d7;௫Ĵb;&#ff0e;Nba;b9a;a3a;Aad;IJe; Lee;Ḅ௻?a1;5d6;௯Ĵc;ıf;̩d;˯f;ʳc;b5;f3;d7;eb;5ca;ఁ,̩d;Ofb;ʲd;IJe;ωb; IJb;˯f;௲Ĵb;<a3;ὅIJe;᤺3fa;̩d;İb;఑̩d;c97;̳c;ᑖ˱b;ఔabf;Xfd;௱, BSEP ˿a;Ife;[cf;ఔa55;fa1;௱ıf;௼௭Ĵd;,᤺3fa;̩d;௻d04; 3 Ǵd;IJe; ᜉ4a0;İc;a8d;ఉ఑Ĵc;&#f;&#ff0e; 7) ije;ıf;,4PB IJe;ʞd;ᵨξb;;cb;f8c;IJb;⊈ 1009 Fig. 2. Login to comment